Major Depressive Disorder
Conditions
Interventions
Measurement -Based and AI-supported care along with usual care
Treatment as usual
Sponsors
Keio University
Himorogi Psychiatric Institute
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (Patients) 1. Those who meet the diagnostic criteria for depression in DSM-5 2. Those who understand the purpose and content of this study and have obtained written consent from the individual to participate in the study of their own free will (Medical Doctors) 1. Outpatient doctors who are in charge of above patient 2. Those who understand the purpose and content of this study and have obtained written consent from the individual to participate in the study of their own free will
Exclusion criteria
Exclusion criteria: (Patients) 1. Those with a history of severe organic brain lesions or cognitive dysfunction 2. Those with a clinically diagnosed life-threatening or unstable physical condition at the time of screening 3. Those who are unable to visit the hospital more than twice within 3 months of participation in the study 4. Others deemed by the principal investigator to be ineligible for the study (Medical Doctors) N/A
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Shared Decision Making Scale (SDM-Q-9 or SDM-Q-Doc) score and Client Satisfaction (CSQ-8J) at the time of end of intervention period | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Coincident ratio between patient shared decision making (DSM-Q-9) and physician shared decision making (SDM-Q-Doc) 2. Remission rate of depression 3. Tool issues, frequency of tool use 4. Trust in physicians (TPS) 5. Depressive symptoms (HAMD, MADRS, BDI-II) 6. Satisfaction with the care using the tool (CSQ-8J) | — |
Countries
Japan
Contacts
Public ContactToshiaki Kikuchi
Keio University School of Medicine Department of Neuropsychiatry
Outcome results
None listed